Immune Thrombocytopenia in Pregnancy

Hematology/Oncology Clinics of North America

Volumn 23, Issue 6, 2009, Pages 1299-1316

  Stavrou, Evi ^a   McCrae, Keith R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immune thrombocytopenia; Microangiopathic; Preeclampsia; Pregnancy; Thrombocytopenia; Thrombotic thrombocytopenic purpura

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; ELTROMBOPAG; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; ROMIPLOSTIM;

AUTOIMMUNE THROMBOCYTOPENIA; BRAIN HEMORRHAGE; CESAREAN SECTION; CLINICAL FEATURE; DELIVERY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG COST; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; FETAL HEMORRHAGE; HELLP SYNDROME; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERTENSION; LOW DRUG DOSE; LYMPHOMA; MATERNAL CARE; NEONATAL HEMORRHAGE; NONHUMAN; OSTEOLYSIS; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOLUTIO PLACENTAE; SPLENECTOMY; TERATOGENICITY; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; WEIGHT GAIN;

FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 70449652576     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2009.08.005     Document Type: Review

References (128)

1. McCrae K. Thrombocytopenia in pregnancy. In: Michelson A. (Ed). Platelets (2006), Elsevier, New York
2. McCrae K.R. Thrombocytopenia in pregnancy: differential diagnosis, pathogenesis, and management. Blood Rev 17 1 (2003) 7-14
3. McCrae K.R., Bussel J.B., Mannucci P.M., et al. Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematology Am Soc Hematol Educ Program 100 (2001) 282-305
4. McCrae K.R., and Cines D.B. Thrombotic microangiopathy during pregnancy. Semin Hematol 34 2 (1997) 148-158
5. McMinn J.R., and George J.N. Evaluation of women with clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome during pregnancy. J Clin Apher 16 4 (2001) 202-209
6. Crowther M.A., Burrows R.F., Ginsberg J., et al. Thrombocytopenia in pregnancy: diagnosis, pathogenesis and management. Blood Rev 10 1 (1996) 8-16
7. Kelton J.G. Idiopathic thrombocytopenic purpura complicating pregnancy. Blood Rev 16 1 (2002) 43-46
8. Cines D.B., Bussel J.B., Liebman H.A., et al. The ITP syndrome: pathogenic and clinical diversity. Blood 113 26 (2009) 6511-6521
9. Provan D., and Newland A. Idiopathic thrombocytopenic purpura in adults. J Pediatr Hematol Oncol 25 Suppl 1 (2003) S34-S38
10. McCrae K.R., Samuels P., and Schreiber A.D. Pregnancy-associated thrombocytopenia: pathogenesis and management. Blood 80 11 (1992) 2697-2714
11. Gill K.K., and Kelton J.G. Management of idiopathic thrombocytopenic purpura in pregnancy. Semin Hematol 37 3 (2000) 275-289
12. McMillan R. Immune-mediated thrombocytopenias: focus on chronic immune thrombocytopenic purpura. Semin Hematol 44 4 Suppl 5 (2007) S1-S2
13. Baldini M. Idiopathic thrombocytopenic purpura. N Engl J Med 274 24 (1966) 1360-1367
14. Cines D.B., and Blanchette V.S. Immune thrombocytopenic purpura. N Engl J Med 346 13 (2002) 995-1008
15. Harrington W.J., Minnich V., Hollingsworth J.W., et al. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38 1 (1951) 1-10
16. Cines D.B., and McMillan R. Management of adult idiopathic thrombocytopenic purpura. Annu Rev Med 56 (2005) 425-442
17. Cines D.B., and Schreiber A.D. Immune thrombocytopenia: use of a Coombs antiglobulin test to detect IgG and C3 on platelets. N Engl J Med 300 3 (1979) 106-111
18. Chang M., Nakagawa P.A., Williams S.A., et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood 102 3 (2003) 887-895
19. McMillan R., Wang L., Tomer A., et al. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood 103 4 (2004) 1364-1369
20. McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol 44 4 Suppl 5 (2007) S3-11
21. Devendra K., and Koh L.P. Pregnancy in women with idiopathic thrombocytopaenic purpura. Ann Acad Med Singapore 31 3 (2002) 276-280
22. Won Y.W., Moon W., Yun Y.S., et al. Clinical aspects of pregnancy and delivery in patients with chronic idiopathic thrombocytopenic purpura (ITP). Korean J Intern Med 20 2 (2005) 129-134
23. Webert K.E., Mittal R., Sigouin C., et al. A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood 102 13 (2003) 4306-4311
24. Boehlen F., Hohlfeld P., Extermann P., et al. Maternal antiplatelet antibodies in predicting risk of neonatal thrombocytopenia. Obstet Gynecol 93 2 (1999) 169-173
25. Shehata N., Burrows R., and Kelton J.G. Gestational thrombocytopenia. Clin Obstet Gynecol 42 2 (1999) 327-334
26. Sainio S., Kekomaki R., Riikonen S., et al. Maternal thrombocytopenia at term: a population-based study. Acta Obstet Gynecol Scand 79 9 (2000) 744-749
27. Samuels P., Main E.K., Tomaski A., et al. Abnormalities in platelet antiglobulin tests in preeclamptic mothers and their neonates. Am J Obstet Gynecol 157 1 (1987) 109-113
28. Burrows R.F., and Kelton J.G. Incidentally detected thrombocytopenia in healthy mothers and their infants. N Engl J Med 319 3 (1988) 142-145
29. Samuels P., Bussel J.B., Braitman L.E., et al. Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura. N Engl J Med 323 4 (1990) 229-235
30. Pridjian G., and Puschett J.B. Preeclampsia. Part 1: clinical and pathophysiologic considerations. Obstet Gynecol Surv 57 9 (2002) 598-618
31. O'Brien J.M., and Barton J.R. Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol 48 2 (2005) 460-477
32. Barton J.R., and Sibai B.M. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol 31 4 (2004) 807-833 vii
33. Nardi M., and Karpatkin S. Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients. J Exp Med 191 12 (2000) 2093-2100
34. Ajzenberg N., Dreyfus M., Kaplan C., et al. Pregnancy-associated thrombocytopenia revisited: assessment and follow-up of 50 cases. Blood 92 12 (1998) 4573-4580
35. Letsky E.A., and Greaves M. Guidelines on the investigation and management of thrombocytopenia in pregnancy and neonatal alloimmune thrombocytopenia. Maternal and Neonatal Haemostasis Working Party of the Haemostasis and Thrombosis Task Force of the British Society for Haematology. Br J Haematol 95 1 (1996) 21-26
36. George J.N., Woolf S.H., Raskob G.E., et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88 1 (1996) 3-40
37. British Committee for Standards in Haematology General Haematology Task Force. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy. Br J Haematol 120 4 (2003) 574-596
38. Fujimura K., Harada Y., Fujimoto T., et al. Nationwide study of idiopathic thrombocytopenic purpura in pregnant women and the clinical influence on neonates. Int J Hematol 75 4 (2002) 426-433
39. Kelton J.G. Management of the pregnant patient with idiopathic thrombocytopenic purpura. Ann Intern Med 99 6 (1983) 796-800
40. Carloss H.W., McMillan R., and Crosby W.H. Management of pregnancy in women with immune thrombocytopenic purpura. JAMA 244 24 (1980) 2756-2758
41. Moise Jr. K.J. Autoimmune thrombocytopenic purpura in pregnancy. Clin Obstet Gynecol 34 1 (1991) 51-63
42. Kessler I., Lancet M., Borenstein R., et al. The obstetrical management of patients with immunologic thrombocytopenic purpura. Int J Gynaecol Obstet 20 1 (1982) 23-28
43. Christiaens G.C., Nieuwenhuis H.K., von dem Borne A.E., et al. Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count. Br J Obstet Gynaecol 97 10 (1990) 893-898
44. Kallen B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J 40 6 (2003) 624-628
45. Pradat P., Robert-Gnansia E., Di Tanna G.L., et al. First trimester exposure to corticosteroids and oral clefts. Birth Defects Res A Clin Mol Teratol 67 12 (2003) 968-970
46. Teeling J.L., Jansen-Hendriks T., Kuijpers T.W., et al. Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia. Blood 98 4 (2001) 1095-1099
47. Cines D.B., and Bussel J.B. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 106 7 (2005) 2244-2251
48. Bussel J.B. Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura. Semin Hematol 37 1 Suppl 1 (2000) 1-4
49. Griffiths J., Sia W., Shapiro A.M., et al. Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy. J Obstet Gynaecol Can 27 8 (2005) 771-774
50. Bar Oz B., Hackman R., Einarson T., et al. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 71 8 (2001) 1051-1055
51. Cote C.J., Meuwissen H.J., and Pickering R.J. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatr 85 3 (1974) 324-328
52. Herold M., Schnohr S., and Bittrich H. Efficacy and safety of a combined rituximab chemotherapy during pregnancy. J Clin Oncol 19 14 (2001) 3439
53. Marushak A., Weber T., Bock J., et al. Pregnancy following kidney transplantation. Acta Obstet Gynecol Scand 65 6 (1986) 557-559
54. Brown J.H., Maxwell A.P., and McGeown M.G. Outcome of pregnancy following renal transplantation. Ir J Med Sci 160 8 (1991) 255-256
55. Bar J., Stahl B., Hod M., et al. Is immunosuppression therapy in renal allograft recipients teratogenic? A single-center experience. Am J Med Genet A 116A 1 (2003) 31-36
56. Ojeda-Uribe M., Gilliot C., Jung G., et al. Administration of rituximab during the first trimester of pregnancy without consequences for the newborn. J Perinatol 26 4 (2006) 252-255
57. Klink D.T., van Elburg R.M., Schreurs M.W., et al. Rituximab administration in third trimester of pregnancy suppresses neonatal B-cell development. Clin Dev Immunol 2008 (2008) 271363
58. Kimby E., Sverrisdottir A., and Elinder G. Safety of rituximab therapy during the first trimester of pregnancy: a case history. Eur J Haematol 72 4 (2004) 292-295
59. Beilin Y., Zahn J., and Comerford M. Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000 mm(-3). Anesth Analg 85 2 (1997) 385-388
60. Schlamowitz M. Membrane receptors in the specific transfer of immunoglobulins from mother to young. Immunol Commun 5 6 (1976) 481-500
61. Leach L., Eaton B.M., Firth J.A., et al. Immunogold localisation of endogenous immunoglobulin-G in ultrathin frozen sections of the human placenta. Cell Tissue Res 257 3 (1989) 603-607
62. Stuart S.G., Simister N.E., Clarkson S.B., et al. Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium. EMBO J 8 12 (1989) 3657-3666
63. Burrows R.F., and Kelton J.G. Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv 48 12 (1993) 781-788
64. Christiaens G.C., Nieuwenhuis H.K., and Bussel J.B. Comparison of platelet counts in first and second newborns of mothers with immune thrombocytopenic purpura. Obstet Gynecol 90 4 Part 1 (1997) 546-552
65. Payne S.D., Resnik R., Moore T.R., et al. Maternal characteristics and risk of severe neonatal thrombocytopenia and intracranial hemorrhage in pregnancies complicated by autoimmune thrombocytopenia. Am J Obstet Gynecol 177 1 (1997) 149-155
66. Garmel S.H., Craigo S.D., Morin L.M., et al. The role of percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura. Prenat Diagn 15 5 (1995) 439-445
67. Christiaens G.C. Immune thrombocytopenic purpura in pregnancy. Baillieres Clin Haematol 11 2 (1998) 373-380
68. Song T.B., Lee J.Y., Kim Y.H., et al. Low neonatal risk of thrombocytopenia in pregnancy associated with immune thrombocytopenic purpura. Fetal Diagn Ther 14 4 (1999) 216-219
69. Cook R.L., Miller R.C., Katz V.L., et al. Immune thrombocytopenic purpura in pregnancy: a reappraisal of management. Obstet Gynecol 78 4 (1991) 578-583
70. Territo M., Finklestein J., Oh W., et al. Management of autoimmune thrombocytopenia in pregnancy and in the neonate. Obstet Gynecol 41 4 (1973) 579-584
71. Jones R.W., Asher M.I., Rutherford C.J., et al. Autoimmune (idiopathic) thrombocytopenic purpura in pregnancy and the newborn. Br J Obstet Gynaecol 84 9 (1977) 679-683
72. Scott J.R., Cruikshank D.P., Kochenour N.K., et al. Fetal platelet counts in the obstetric management of immunologic thrombocytopenic purpura. Am J Obstet Gynecol 136 4 (1980) 495-499
73. Moise Jr. K.J., Carpenter Jr. R.J., Cotton D.B., et al. Percutaneous umbilical cord blood sampling in the evaluation of fetal platelet counts in pregnant patients with autoimmune thrombocytopenia purpura. Obstet Gynecol 72 3 Pt 1 (1988) 346-350
74. Scioscia A.L., Grannum P.A., Copel J.A., et al. The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura. Am J Obstet Gynecol 159 5 (1988) 1066-1068
75. Burrows R.F., and Kelton J.G. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol 163 4 Pt 1 (1990) 1147-1150
76. Kelton J.G., Inwood M.J., Barr R.M., et al. The prenatal prediction of thrombocytopenia in infants of mothers with clinically diagnosed immune thrombocytopenia. Am J Obstet Gynecol 144 4 (1982) 449-454
77. Moutet A., Fromont P., Farcet J.P., et al. Pregnancy in women with immune thrombocytopenic purpura. Arch Intern Med 150 10 (1990) 2141-2145
78. Karpatkin M., Porges R.F., and Karpatkin S. Platelet counts in infants of women with autoimmune thrombocytopenia: effects of steroid administration to the mother. N Engl J Med 305 16 (1981) 936-939
79. Laros R.K., and Sweet R.L. Management of idiopathic thrombocytopenic purpura during pregnancy. Am J Obstet Gynecol 122 2 (1975) 182-191
80. Wahbeh C.J., Eden R.D., Killam A.P., et al. Pregnancy and immune thrombocytopenic purpura. Am J Obstet Gynecol 149 2 (1984) 238-240
81. Verdy E., Bessous V., Dreyfus M., et al. Longitudinal analysis of platelet count and volume in normal pregnancy. Thromb Haemost 77 4 (1997) 806-807
82. Burrows R.F., and Kelton J.G. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 329 20 (1993) 1463-1466
83. Burrows R.F., and Kelton J.G. Thrombocytopenia at delivery: a prospective survey of 6715 deliveries. Am J Obstet Gynecol 162 3 (1990) 731-734
84. Matthews J.H., Benjamin S., Gill D.S., et al. Pregnancy-associated thrombocytopenia: definition, incidence and natural history. Acta Haematol 84 1 (1990) 24-29
85. Cunningham F.G., and Lindheimer M.D. Hypertension in pregnancy. N Engl J Med 326 14 (1992) 927-932
86. Lindheimer M.D., and Katz A.I. Hypertension in pregnancy. N Engl J Med 313 11 (1985) 675-680
87. Rauramo L. The incidence of eclampsia in Finland, 1927-1958. Pathol Microbiol 24 (1961) 435-443
88. Sibai B.M. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102 1 (2003) 181-192
89. Esplin M.S., Fausett M.B., Fraser A., et al. Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med 344 12 (2001) 867-872
90. Romero R., and Duffy T.P. Platelet disorders in pregnancy. Clin Perinatol 7 2 (1980) 327-348
91. Romero R., Lockwood C., Oyarzun E., et al. Toxemia: new concepts in an old disease. Semin Perinatol 12 4 (1988) 302-323
92. Redman C.W. Current topic: pre-eclampsia and the placenta. Placenta 12 4 (1991) 301-308
93. Lindheimer M.D., and Katz A.I. Preeclampsia: pathophysiology, diagnosis, and management. Annu Rev Med 40 (1989) 233-250
94. Brosens I., Dixon H.G., and Robertson W.B. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 84 9 (1977) 656-663
95. De Wolf F., Brosens I., and Renaer M. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 87 8 (1980) 678-685
96. Meekins J.W., Pijnenborg R., Hanssens M., et al. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 101 8 (1994) 669-674
97. Zhou Y., Damsky C.H., Chiu K., et al. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 91 3 (1993) 950-960
98. Bussolino F., Benedetto C., Massobrio M., et al. Maternal vascular prostacyclin activity in pre-eclampsia. Lancet 2 8196 (1980) 702
99. Geary M. The HELLP syndrome. Br J Obstet Gynaecol 104 8 (1997) 887-891
100. Karumanchi S.A., Maynard S.E., Stillman I.E., et al. Preeclampsia: a renal perspective. Kidney Int 67 6 (2005) 2101-2113
101. Magann E.F., and Martin Jr. J.N. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol 42 3 (1999) 532-550
102. Audibert F., Friedman S.A., Frangieh A.Y., et al. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 175 2 (1996) 460-464
103. Padden M.O. HELLP syndrome: recognition and perinatal management. Am Fam Physician 60 3 (1999) 829-836 839
104. Stone J.H. HELLP syndrome: hemolysis, elevated liver enzymes, and low platelets. JAMA 280 6 (1998) 559-562
105. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142 2 (1982) 159-167
106. Sibai B.M. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?. Am J Obstet Gynecol 162 2 (1990) 311-316
107. Thiagarajah S., Bourgeois F.J., Harbert Jr. G.M., et al. Thrombocytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol 150 1 (1984) 1-7
108. Ridolfi R.L., and Bell W.R. Thrombotic thrombocytopenic purpura: report of 25 cases and review of the literature. Medicine (Baltimore) 60 6 (1981) 413-428
109. Sibai B.M. Imitators of severe pre-eclampsia/eclampsia. Clin Perinatol 31 4 (2004) 835-852 vii-viii
110. Levy G.G., Nichols W.C., Lian E.C., et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 413 6855 (2001) 488-494
111. Mayer S.A., and Aledort L.M. Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies. Mt Sinai J Med 72 3 (2005) 166-175
112. Furlan M., Robles R., Galbusera M., et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339 22 (1998) 1578-1584
113. Sanchez-Luceros A., Farias C.E., Amaral M.M., et al. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thromb Haemost 92 6 (2004) 1320-1326
114. Tsai H.M., and Lian E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339 22 (1998) 1585-1594
115. Karmali M.A., Petric M., Lim C., et al. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 151 5 (1985) 775-782
116. McCrae K.R., Sadler J.E., and Cines D.B. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. In: Hoffman R., Benz E.J.J., and Shattil S.J. (Eds). Hematology: basic principles and practice (2005), Elsevier, Churchill, Livingstone, Philadelphia 2287
117. Bick R.L. Disseminated intravascular coagulation and related syndromes: a clinical review. Semin Thromb Hemost 14 4 (1988) 299-338
118. Ratnoff O.D., Pritchard J.A., and Colopy J.E. Hemorrhagic states during pregnancy. N Engl J Med 253 3 (1955) 97-102
119. Purdie F.R., Nieto J.M., Summerson D.J., et al. Rupture of the uterus with DIC. Ann Emerg Med 12 3 (1983) 174-176
120. Bick R.L. Syndromes of disseminated intravascular coagulation in obstetrics, pregnancy, and gynecology: objective criteria for diagnosis and management. Hematol Oncol Clin North Am 14 5 (2000) 999-1044
121. Knox T.A., and Olans L.B. Liver disease in pregnancy. N Engl J Med 335 8 (1996) 569-576
122. Abramowicz J.S., Sherer D.M., and Woods Jr. J.R. Acute transient thrombocytopenia associated with cocaine abuse in pregnancy. Obstet Gynecol 78 3 Pt 2 (1991) 499-501
123. Gimovsky M.L., and Montoro M. Systemic lupus erythematosus and other connective tissue diseases in pregnancy. Clin Obstet Gynecol 34 1 (1991) 35-50
124. Budman D.R., and Steinberg A.D. Hematologic aspects of systemic lupus erythematosus: current concepts. Ann Intern Med 86 2 (1977) 220-229
125. Weiner C.P. The mechanism of reduced antithrombin III activity in women with preeclampsia. Obstet Gynecol 72 6 (1988) 847-849
126. Schiff E., Peleg E., Goldenberg M., et al. The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med 321 6 (1989) 351-356
127. Cunningham F.G., and Gant N.F. Prevention of preeclampsia-a reality?. N Engl J Med 321 9 (1989) 606-607
128. Lockwood C.J., and Peters J.H. Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 162 2 (1990) 358-362